Background Image
Table of Contents Table of Contents
Previous Page  12 / 40 Next Page
Information
Show Menu
Previous Page 12 / 40 Next Page
Page Background

12

Israel-India Business Guide - MedTech, Pharma & Biotech

Providing Opportunities

for interaction between

industry and policy makers

FICCI Life Sciences works closely with the government on

policy issues, enhancing efficiency, competitiveness and

expanding business opportunities for industry through

a range of specialized services and global linkages. It

also provides a platform for sector specific consensus

building and networking. It has been actively involved

in organizing conferences and seminars, providing an

opportunity for interaction between the industry and

the policy makers, to identify the various impediments

to the growth and functioning of the industry and to

come out with prospective solutions for the same.

FICCI Life Sciences comprises of three major sectors:

Biotechnology

FICCI has led an initiative of formulating Biotechnology

Committee. First Biotech Committee Meeting was held

on 12th April, 2011 where in several issues has been

discussed. Committee is still in the process of identifying

policy issues within the Sector. The issues which have

which has been identified and deliberated in the first

meeting are as under:

• Engage with DCGI and other concerned officials: to Map

out the hurdles in the process of Product clearances

• Emphasis on Industry- Academia bridging: to gaps

between Industry and Academia

• Emphasis on the funding programs: to improvisation of

the Government Funding Schemes and awareness

• Revive the Industry platform: to bridge the gap by

bringing together industry, academia, policy planners

and all other stakeholders to define and implement

an industry driven research agenda, provides industry

an opportunity to contribute ideas for public funded

research

Apart from the above identified issues FICCI is also focusing

on three major areas in the Biotech Sector:

• Similar Biologics/Biosimilars

• Vaccines

• Stem Cells

• Clinical Research

FICCI Taskforce on Clinical Research works closely with

government on policy issues, enhancing efficiency,

competitiveness and expanding business opportunities for

Clinical Research Industry.

FICCI had led the initiative with support of government

to highlight the strengths and potential of Indian Clinical

Research Industry by participating in 45th Annual DIA

Meeting, in San Diego, USA, and organized various India-

focused programmes.

Pharmaceuticals

FICCI in partnership with the Department of

Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers

organizes the "India Pharma Summit", an annual event

of the DoP. This event provides a platform to the various

stakeholders to address key issues, identify challenges

and chart a road map for India to take a rightful place

as a destination of choice Drug Discovery, Research &

Development, Manufacturing and realize its full potential

to become globally competitive.

India Pharma Summit, March 20, 2014-Mumbai

Dr. Arbind Prasad, Director General, FICCI at India

Pharma Summit, March 20, 2014 in Mumbai

Overview of Life Sciences Sector of FICCI

MedTech